Literature DB >> 2839215

Cirrhotic process, liver cell carcinoma and extrahepatic malignant tumors in idiopathic haemochromatosis. Study of 71 patients treated with venesection therapy.

G Tiniakos1, R Williams.   

Abstract

A detailed morphological study concerning the liver of 71 patients suffering from idiopathic haemochromatosis was carried out. These patients were subjected to long-term venesection therapy, which lasted from 1 to 12 years. The mean duration of therapy was 7 years for each patient. The material consisted of needle biopsies of the liver. Three to seven biopsies were performed in each patient; the initial biopsy, the biopsy following venesection therapy, and the follow-up biopsies. In 30 cases the follow-up was performed in autopsy material. It was found that the final histological appearance of the liver remained unchanged in 44 (62%) cases, became worse in 23 (32%) cases, and improved in 4 (5%) cases. However, the change for the worse is generally retarded and consequently the mean survival of the patients is increased. Two out of 4 cases that showed improvement (i.e. changing from cirrhosis to fibrosis) are strongly supported by the fact that the follow-up study was performed in autopsy material after 2-5 needle liver biopsies. A high incidence of hepatocellular carcinoma (18%), as well as of a malignant neoplasia in another organ (8.4%), was noted in spite of the long-term venesection therapy. It follows therefore that the longer survival of patients with idiopathic haemochromatosis increases the possibility of hepatocellular carcinoma or of a malignancy in another organ.

Entities:  

Mesh:

Year:  1988        PMID: 2839215

Source DB:  PubMed          Journal:  Appl Pathol        ISSN: 0252-1172


  8 in total

1.  Need for early recognition and therapeutic guidelines of congenital sideroblastic anaemia.

Authors:  M L H Cuijpers; D J van Spronsen; P Muus; B C J Hamel; D W Swinkels
Journal:  Int J Hematol       Date:  2011-06-08       Impact factor: 2.490

2.  HODGKIN'S DISEASE WITH IDIOPATHIC HEMOCHROMATOSIS.

Authors:  G U Deshpande; A C Anand; Ramji Rai
Journal:  Med J Armed Forces India       Date:  2017-06-26

Review 3.  Overview of hemochromatosis.

Authors:  L H Smith
Journal:  West J Med       Date:  1990-09

4.  Prognostic factors and survival in patients with hereditary hemochromatosis and cirrhosis.

Authors:  Melanie D Beaton; Paul C Adams
Journal:  Can J Gastroenterol       Date:  2006-04       Impact factor: 3.522

5.  Cytogenetic, developmental, and biochemical effects of aluminum, iron, and their mixture in sea urchins and mussels.

Authors:  G Pagano; E His; R Beiras; A De Biase; L G Korkina; M Iaccarino; R Oral; F Quiniou; M Warnau; N M Trieff
Journal:  Arch Environ Contam Toxicol       Date:  1996-11       Impact factor: 2.804

6.  Expression of E-cadherin and other paracellular junction genes is decreased in iron-loaded hepatocytes.

Authors:  John P Bilello; Edward E Cable; Harriet C Isom
Journal:  Am J Pathol       Date:  2003-04       Impact factor: 4.307

7.  HFE C282Y and H63D in adults with malignancies in a community medical oncology practice.

Authors:  James C Barton; Luigi F Bertoli; Ronald T Acton
Journal:  BMC Cancer       Date:  2004-02-10       Impact factor: 4.430

8.  Risk of hematological malignancy in blood donors: A nationwide cohort study.

Authors:  Jingcheng Zhao; Torsten Dahlén; Anne Brynolf; Gustaf Edgren
Journal:  Transfusion       Date:  2020-08-20       Impact factor: 3.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.